New shot aims to slash hepatitis b virus levels
Disease control
Completed
This study tested an experimental injection called RBD1016 in 48 adults with chronic hepatitis B who were already taking standard antiviral pills. The main goals were to see if the injection is safe and if it can lower hepatitis B surface antigen (HBsAg) levels in the blood. Part…
Phase: PHASE2 • Sponsor: Suzhou Ribo Life Science Co. Ltd. • Aim: Disease control
Last updated May 17, 2026 11:54 UTC